ATAI (Atai Life Sciences N.V.) Stock Market Reviews

crown

search

Read and share opinions on ATAI (Atai Life Sciences N.V.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ATAI

Atai Life Sciences N.V.

clarify Biotechnology

bookmark Healthcare

public Netherlands

Sell Neutral Buy

Latest News

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
Nov 13, 2025
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Nov 12, 2025
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
Nov 5, 2025
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
Oct 20, 2025
atai Life Sciences (ATAI) Upgraded to Buy: Here's Why
Oct 20, 2025
Atai Life Sciences (ATAI): Evaluating Valuation After FDA Breakthrough Therapy Designation for BPL-003
Oct 18, 2025
atai Life Sciences Announces Pricing of Public Offering of Common Shares
Oct 17, 2025
atai Life Sciences Announces Proposed Public Offering of Common Shares
Oct 16, 2025
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
Oct 16, 2025
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing
Oct 2, 2025
Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight
Sep 23, 2025
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
Sep 23, 2025
Atai, Beckley Report Positive Phase 2a Results for Intranasal BPL-003 in Treatment-Resistant Depression
Sep 23, 2025
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Sep 22, 2025

Reviews